Our Focus is on Discovering New Treatments for Cancer

When it opened in 1985, Maryland Office of Clinical Research had the honor of becoming the first research institute to be established by a Japanese pharmaceutical company in the U.S. Its aim was to discover and support innovative healthcare products that address unanswered medical needs. Known today as Otsuka Maryland Medicinal Laboratories, Inc. (OMML), it has since become an important part of the Otsuka Group and focuses on discovering pharmacologically active small compounds and bio-therapeutics that could make a real difference in treating cancer. OMML carries out basic and applied research as part of Otsuka’s international research organization that supports drug discovery across the globe.


Otsuka Maryland Medicinal Laboratories, Inc. established
"We end each day full of satisfaction for the progress we have made towards making a real difference in treating cancer."
Takayuki Shiratsuchi, Ph.D. President & CEO, OMML
Takayuki Shiratsuchi

Meet our leadership team and discover their vision for our company

Dr. Takayuki ShiratsuchiPh.D.
President & CEO, OMML


Fighting cancer is a priority at Otsuka. We target cancers like leukemia that have a high mortality rate.

The talented people at Otsuka US have dreams, a passion to succeed, huge perseverance and a willingness to embrace our creative and innovative culture. We believe that we provide the perfect working environment for them to grow, but don’t just take our word for it. Let our employees tell you for themselves about why Otsuka US is such a great place to work.